Table 1.
Patient characteristics and type of primary permanent vascular accessa
| Overall | Male | Female | P-value | |
|---|---|---|---|---|
| Number | 246 | 138 (56) | 108 (44) | |
| Age (years) | 65.3 [15.2–89.6] | 63.6 [15.2–88.1] | 65.9 [20.9–89.6] | 0.7b |
| BMI | 23.5 [11.8–50.9] | 24.1 [16.7–50.9] | 22.3 [11.8–37.0] | 0.004b |
| Diabetes mellitus | 89 (36) | 56 (41) | 33 (31) | 0.1c |
| Type 1 | 10 (4) | 4 (3) | 6 (6) | 0.3c |
| Type 2 | 79 (32) | 52 (38) | 27 (25) | 0.04c |
| Vascular disease | 122 (50) | 70 (51) | 52 (48) | 0.7c |
| CAD | 69 (28) | 44 (32) | 25 (23) | 0.2c |
| PAD | 70 (29) | 39 (29) | 31 (29) | 1.0c |
| CVD | 39 (16) | 22 (16) | 17 (16) | 1.0c |
| Malignancies | 65 (27) | 35 (26) | 30 (28) | 0.8c |
| AID | 19 (8) | 8 (6) | 11 (10) | 0.2c |
| Underlying kidney disease | ||||
| Diabetes mellitus | 45 (18) | 28 (20) | 17 (16) | 0.4c |
| ADPKD | 23 (9) | 11 (8) | 12 (11) | 0.5c |
| Analgesic nephropathy | 16 (7) | 3 (2) | 13 (12) | 0.003c |
| Glomerulonephritis | 29 (12) | 18 (13) | 11 (10) | 0.6c |
| Interstitial nephropathy | 3 (1) | 2 (2) | 1 (1) | 1.0c |
| Vascular nephropathy | 38 (15) | 23 (17) | 15 (14) | 0.6c |
| Otherd | 63 (26) | 40 (29) | 23 (21) | 0.2c |
| Unknown | 29 (12) | 13 (9) | 16 (15) | 0.2c |
| Type of vascular access | ||||
| AVF | 211 (86) | 123 (89) | 88 (82) | 0.1c |
| AVG | 16 (6) | 6 (4) | 10 (9) | 0.2c |
| PC | 19 (8) | 9 (7) | 10 (9) | 0.5c |
aData are displayed as counts (%) or median [range]. Vascular disease: including all patients suffering from at least one subgroup of CAD, PAD or CVD. CAD, coronary artery disease; PAD, peripheral arterial disease; CVD, cerebrovascular disease; AID, autoimmune disease; ADPKD, autosomal dominant polycystic kidney disease; AVF, native arterio-venous fistula; AVG, arterio-venous graft; PC, permanent catheter.
bMann–Whitney test.
cFisher's exact test.
dAmong others primary focal segmental glomerulosclerosis (n = 13), nephrectomy due to renal cell carcinoma (n = 7), atheroembolic renal disease (n = 4), amyloidosis (n = 4), multiple myeloma (n = 4) and reflux nephropathy (n = 4).